WCN23-1085 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATY- THE ALIGN STUDY

Autor: Lambers Heerspink, H., Jardine, M., Kohan, D.E., Lafayette, R., Levin, A., Liew, A., Zhang, H., Sheth, K., Camargo, M., Jones-Burton, C., King, A.J., Barratt, J.
Zdroj: In Kidney International Reports March 2023 8(3) Supplement:S279-S280
Databáze: ScienceDirect